Testing a Marker to Predict Liver Transplant Success

This international research study is testing whether a natural substance called Flavin Mononucleotide (FMN) — measured in the fluid used to preserve and warm a donor liver before transplant — can accurately predict how well a transplanted liver will function after surgery. Researchers believe this marker could help doctors decide which donated livers are safe to transplant and identify which patients might need closer monitoring after their transplant.

Right now, doctors use several different methods to test whether a donated liver is healthy enough to transplant, but there is no single agreed-upon standard. This medication shows promise in early studies as a reliable way to spot problems before they happen, potentially reducing transplant failures and serious complications.